John has served as Impel’s Chief Scientific Officer since July 2008. John spent the last 10 years investigating intranasal drug delivery to the brain. He started this work at the Alzheimer’s Research Center in St. Paul, MN under Dr. William H. Frey II. John then attended graduate school at the University of Washington, where he invented the POD technology and made contributions to understanding intranasal drug delivery to the brain. To further advance his work, John co-founded Impel in 2008 while still in graduate school. He holds a BS in Physics from the University of Minnesota and a Ph.D. in Pharmaceutics from the University of Washington.